Román Fernández Ana, Gómez Ávila Jessica
Hospital Universitario Virgen Macarena, Neonatology Department, Sevilla, Spain.
Hospital Universitario Virgen Macarena, Neonatology Department, Sevilla, Spain.
J Pediatr (Rio J). 2025 Aug 18;101(5):101425. doi: 10.1016/j.jped.2025.101425.
To investigate whether the use of a biparametric score, based on lung ultrasound (LUS) and oxygen saturation/fraction of inspired oxygen ratio (SF ratio), in preterm infants with respiratory distress syndrome (RDS) allows earlier surfactant therapy (first 3 hours of life) compared to classic FiO criteria.
Before-after design study, performed in a tertiary neonatal intensive care unit. Inclusion criteria were newborns with gestational age < 34 weeks with clinical RDS and respiratory support with noninvasive ventilation. The patients were divided into two groups, the control group, with surfactant indication according to classic criteria, collected retrospectively, and the new protocol group, with surfactant criteria according to biparametric score.
61 patients were included. The new protocol group received surfactant earlier (all patients in the first 3 hours, p 0.013). Likewise, after surfactant treatment, newborns in this group required lower FiO (p 0.001) and a better pulmonary ultrasound evolution according to LUS (p 0.008).
Biparametric scoring allowed earlier surfactant therapy and reduced post-treatment oxygen requirement. This protocol offers a more personalized approach tailored to the patient's needs, which helps us in decision-making.
探讨基于肺部超声(LUS)和氧饱和度/吸入氧分数比(SF比)的双参数评分,在呼吸窘迫综合征(RDS)早产儿中与经典的FiO标准相比,是否能更早地进行表面活性剂治疗(出生后3小时内)。
在一家三级新生儿重症监护病房进行前后对照设计研究。纳入标准为孕周<34周、患有临床RDS且采用无创通气进行呼吸支持的新生儿。患者分为两组,回顾性收集的根据经典标准有表面活性剂使用指征的对照组,以及根据双参数评分有表面活性剂使用标准的新方案组。
共纳入61例患者。新方案组更早接受表面活性剂治疗(所有患者在出生后3小时内接受治疗,p=0.013)。同样,在表面活性剂治疗后,该组新生儿需要的FiO更低(p=0.001),并且根据LUS显示肺部超声的演变情况更好(p=0.008)。
双参数评分允许更早地进行表面活性剂治疗,并降低治疗后的氧需求。该方案提供了一种根据患者需求定制的更个性化方法,有助于我们进行决策。